| 141 | 0 | 183 |
| 下载次数 | 被引频次 | 阅读次数 |
系统梳理国医大师王新陆教授基于血浊理论辨治重症肌无力学术思想与临证经验。重症肌无力可归属于中医学痿病范畴,血浊为其发生发展的重要病理因素。王新陆教授认为脾浊阳陷、郁浊化热、血浊阻络、浊损脾肾为其四大核心病机,提出化浊结合健脾升清、清热荣末、通阳疏络、温肾益髓四法。临证时以血浊立论辨治本病,交融诸法,常获显效,为中医学治疗本病与弥合中西分歧提供了新思路。附医案1则。
Abstract:This article systematically reviews the academic thoughts and clinical experience of Professor WANG Xinlu,a master of traditional Chinese medicine(TCM),in diagnosing and treating myasthenia gravis based on the theory of blood turbidity. Myasthenia gravis can be classified under the category of flaccidity disease in TCM,and blood turbidity is an important pathological factor for its occurrence and development. Professor WANG Xinlu believes that the four core pathogenic mechanisms of the disease are spleen turbidity and yang stagnation,turbidity transforming into heat,blood turbidity blocking the collaterals,and turbidity damaging the spleen and kidneys. He proposes four methods:combining turbidity transformation with strengthening the spleen and ascending yang qi,clearing heat and nourishing the extremities,unblocking yang and dredging the collaterals,and warming the kidneys and benefiting the marrow. In clinical practice,the diagnosis and treatment of the underlying disease based on blood turbidity,integrating various methods flexibly often yields remarkable results,which provides a new approach for TCM in treating this disease and bridging the gap between Chinese and Western medicine. One medical case is attached.
[1]DRESSER L,WLODARSKI R,REZANIA K,et al. Myasthenia gravis:epidemiology,pathophysiology and clinical manifestations[J]. J Clin Med,2021,10(11):2235.
[2]LAZARIDIS K,TZARTOS S J. Myasthenia gravis:autoantibody specificities and their role in MG management[J]. Front Neurol,2020,11:596981.
[3]ALHAIDAR M K,ABUMURAD S,SOLIVEN B,et al.Current treatment of myasthenia gravis[J]. J Clin Med,2022,11(6):1597.
[4]FARRUGIA M E,GOODFELLOW J A. A practical approach to managing patients with myasthenia gravisopinions and a review of the literature[J]. Front Neurol,2020,11:604.
[5]王栋先,王新陆.齐鲁内科时病流派学术思想简析[J].广州中医药大学学报,2017,34(6):934-938.
[6]王一晰,黄柏玮.老年重症肌无力免疫学病因及中西医治疗进展[J].老年医学与保健,2024,30(5):1487-1491.
[7]王新陆.“浊”与“血浊”[J].天津中医药,2019,36(9):833-838.
[8]李柏,金妍,王栋先,等.基于血浊理论辨治脑病研究进展[J].山东中医杂志,2025,44(1):112-117,123.
[9]GILHUS N E,TZARTOS S,EVOLI A,et al. Myasthenia gravis[J]. Nat Rev Dis Primers. 2019,5(1):30.
[10]常婷.中国重症肌无力诊断和治疗指南(2020版)[J].中国神经免疫学和神经病学杂志,2021,28(1):1-12.
[11]任英超,于丽红,王新陆.国医大师王新陆从血浊理论探讨血浊与脾胃关系[J].现代中医临床,2025,32(5):73-76.
[12]王丹丹,王业飞,于媛媛,等.从脾与血浊相关论治阿尔茨海默病[J].山东中医杂志,2025,44(7):749-753.
[13]怀宝赓,沈晓玥,乔云,等.浅析血浊与络病[J].北京中医药大学学报,2025,48(6):779-784.
[14]张国丽,刘伟.刍论中医髓病内涵及病机[J].中华中医药杂志,2024,39(7):3331-3335.
[15]王静,刘伟,李鑫.从髓论治中风五法[J].山东中医药大学学报,2021,45(5):604-607.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2026.01.013
中图分类号:R249;R277.7
引用信息:
[1]沈瑛锴,叶全,王栋先,等.国医大师王新陆基于血浊理论辨治重症肌无力经验[J].山东中医杂志,2026,45(01):68-71+87.DOI:10.16295/j.cnki.0257-358x.2026.01.013.
基金信息:
国家中医药管理局第四届国医大师王新陆传承工作室建设项目(批文号:国中医药办人教函[2022]245号); 山东中医药大学研究生提质创新课题项目(编号:YJSTZCX2025142)
2026-01-05
2026-01-05